Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753373 Protease inhibitors as antivirals

Patent 11753373 was granted and assigned to ACEA THERAPEUTICS, INC. on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

ACEA THERAPEUTICS, INC.

Current Assignee

‌

ACEA THERAPEUTICS, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11753373

Patent Inventor Names

Can Jin

Xiao Xu

Long Mao

Namir Shaabani

Date of Patent

September 12, 2023

Patent Application Number

17830185

Date Filed

June 1, 2022

Patent Citations

‌

US Patent 11124497 Inhibitors of cysteine proteases and methods of use thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753373 Protease inhibitors as antivirals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API